Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Japanese Participants”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04872387
What this trial is testing

Learn More About How Safe BAY2586116 is, How it Affects the Body, How it Moves Into, Through and Out of the Body at Different Doses in Healthy Japanese Male Participants After Taking Single and Multiple Doses Through the Nose

Who this might be right for
Obstructive Sleep Apnea
Bayer 36
Early research (Phase 1)Study completedNCT01442532
What this trial is testing

The Safety and Pharmacokinetics of JNJ-38518168 in Japanese and Caucasian Male Participants and the Effect of JNJ-38518168 on the Blood Levels of Midazolam

Who this might be right for
Healthy Male Volunteer
Janssen Research & Development, LLC 94
Early research (Phase 1)Study completedNCT05307978
What this trial is testing

Safety and Tolerability, Pharmacokinetic, and Pharmacodynamic Study of ALXN1910 in Healthy Participants

Who this might be right for
Healthy
Alexion Pharmaceuticals, Inc. 48
Early research (Phase 1)Study completedNCT05056246
What this trial is testing

Study of AMG 133 Administered Subcutaneously in Healthy Japanese and Caucasian Participants

Who this might be right for
Healthy Participants
Amgen 34
Early research (Phase 1)Study completedNCT05989672
What this trial is testing

A Study on the Reactogenicity, Safety and Immune Response of a Targeted Immunotherapy Against HSV in Healthy Japanese Participants Aged 18-40 Years

Who this might be right for
Herpes Simplex
GlaxoSmithKline 50
Early research (Phase 1)WithdrawnNCT05304130
What this trial is testing

A Study in Healthy Japanese Participants to Evaluate the Safety and Pharmacokinetics of Otilimab

Who this might be right for
Arthritis, Rheumatoid
GlaxoSmithKline
Early research (Phase 1)Study completedNCT03579940
What this trial is testing

Lasmiditan in Healthy Japanese and Caucasian Participants

Who this might be right for
Healthy
Eli Lilly and Company 27
Early research (Phase 1)Study completedNCT04427917
What this trial is testing

Study of Multiple Oral Doses of PF-06835919 in Healthy Adult Japanese Participants

Who this might be right for
Healthy
Pfizer 8
Early research (Phase 1)Study completedNCT04500808
What this trial is testing

Macitentan, in Healthy Japanese Male Participants

Who this might be right for
Healthy
Janssen Pharmaceutical K.K. 24
Early research (Phase 1)Not Yet RecruitingNCT07600450
What this trial is testing

GSK4771261 in Healthy Participants Aged 25 to 55 Years of Age Inclusive

Who this might be right for
Kidney Disease
GlaxoSmithKline 30
Early research (Phase 1)Study completedNCT02748967
What this trial is testing

Evaluate the Safety and Immunogenicity of Different Doses of ExPEC4V (JNJ-63871860) in Healthy Japanese Adult Participants

Who this might be right for
Healthy
Janssen Pharmaceutical K.K. 48
Large-scale testing (Phase 3)Study completedNCT04648241
What this trial is testing

Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older

Who this might be right for
Tick-Borne Encephalitis
Pfizer 165
Early research (Phase 1)Study completedNCT04965402
What this trial is testing

Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986166 in Healthy Japanese Participants

Who this might be right for
Healthy Volunteers
Bristol-Myers Squibb 23
Early research (Phase 1)WithdrawnNCT02015533
What this trial is testing

Assess the Safety, Pharmacokinetics and Immunogenicity of CR8020 in Japanese Healthy Participants

Who this might be right for
Healthy
Janssen Pharmaceutical K.K.
Early research (Phase 1)Study completedNCT02430870
What this trial is testing

TAK-648 Multiple-Rising Dose Study in Healthy Japanese Participants and Non-Japanese Participants With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Takeda 48
Early research (Phase 1)Study completedNCT03224260
What this trial is testing

To Evaluate the Safety and Pharmacokinetics of BMS-986177 in Healthy Japanese Participants

Who this might be right for
Thrombosis
Bristol-Myers Squibb 33
Early research (Phase 1)Ended earlyNCT03915886
What this trial is testing

JNJ-64530440 in Healthy Japanese Male Participants

Who this might be right for
Healthy
Janssen Pharmaceutical K.K. 16
Early research (Phase 1)Study completedNCT02641041
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of BIIB033 in Healthy Japanese Participants

Who this might be right for
Central Nervous System (CNS) Demyelinating DiseaseMultiple Sclerosis
Biogen 24
Early research (Phase 1)Study completedNCT02226653
What this trial is testing

Evacetrapib in Healthy Japanese Participants

Who this might be right for
Healthy Volunteers
Eli Lilly and Company 48
Early research (Phase 1)Study completedNCT07176728
What this trial is testing

Assess the Safety and Effects of Different Doses of an Investigational Drug, BAY 3389934, in Healthy Japanese Volunteers.

Who this might be right for
Sepsis Associated Disseminated Intravascular Coagulation (DIC)
Bayer 16
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation